icosapent
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
5 FDA-registered drug labelers
Acella Pharmaceuticals, LLC
Avion Pharmaceuticals, LLC
CarWin Pharmaceutical Associates, LLC
Catalent Pharma Solutions, LLC
Prodose, Inc
Why It Matters
Sectors
Health
Downstream Uses
Appears in 4 drug and cosmetic product listings (FDA).
- •PNV-Omega
- •TriStart DHA
- •Prenate Essential
- •BP Vit 3
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Icosapent Ethyl Capsule
04/01/2026Chemical Identity
CAS10417-94-4
PubChem CID446284
DTXSIDDTXSID9041023
FormulaC20H30O2
Mol. Weight302.5 g/mol
SMILESCCC=CCC=CCC=CCC=CCC=CCCCC(=O)O
Data Sources
4462842026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/icosapent/cids/JSON
Archive: data/sources/pubchem_name/icosapent.json
CAS 10417-94-42026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 10417-94-42026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json